Tech Company Financing Transactions
BioAge Labs Funding Round
On 7/30/2017, BioAge Labs raised $10.9 million in Series A funding from Andreessen Horowitz, AME Cloud Ventures and Caffeinated Capital.
Transaction Overview
Company Name
Announced On
7/30/2017
Transaction Type
Venture Equity
Amount
$10,900,000
Round
Series A
Investors
Andreessen Horowitz (Lead Investor) (Vijay Pande)
private investors (Elad Gil)
Proceeds Purpose
The company intends to use the funds to build the team, refine and test its signatures of aging, and begin in vivo evaluation of drug candidates.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1445A S 50th St.
Richmond, CA 94804
USA
Richmond, CA 94804
USA
Phone
Undisclosed
Website
Email Address
Overview
We couple omics data with machine learning to measure human aging and accelerate drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kristen Fortney
Chief Marketing Officer
Paul Rubin
Chief Operating Officer
Eric Morgen
Chief Scientific Officer
Klaus Klumpp
Controller
Ralph Scarborough
Vice President
Robert Hopkins
Vice President
Robert Hughes
Vice President
Patrick Martin
Vice President
Justin Rebo
VP - Bus. Development
Peng Leong
VP - Regulatory Affairs
Carrie Furr
Browse more venture capital transactions:
Prev: 7/29/2017: Bloomz venture capital transaction
Next: 7/30/2017: Aphelion Orbitals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs